Cencora PharmaLex is pleased to announce the general availability of psiXchange 3.0: the latest release of our software designed specifically to make complex clinical trial safety reporting more efficient and accurate, while reducing cost and effort.  Built and supported by our global team of pharmacovigilance and technology experts, psiXchange 3.0 provides intelligent process automation and […] The post Cencora PharmaLex Introduces psiXchange 3.0: Intelligent, automated clinical trial safety reporting software  appeared first on PharmaLex ..read more

PharmaLex and all the companies in PharmaLex family are now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond all the companies in PharmaLex family will begin a journey to becoming Cencora as well. It’s a name that represents a global focus on empowering our partners … We are becoming Cencora PharmaLex Read More » The post We are becoming Cencora PharmaLex appeared first on PharmaLex ..read more

S.O.L.V.E.-AMR – Solutions for Overcoming and Leveraging Versatile Efforts Against Microbial Resistance [Lyon – Dijon – Paris, Tuesday October 10th, 2023] – BIOASTER, Cynbiose, ICTA, and PharmaLex announced today a strategic collaboration that aims to help combat antimicrobial resistance (AMR). As part of the initiative, the organizations will leverage their collective expertise and capabilities to … Pioneering initiative to Fast-Track Antimicrobials from R&D to commercialization Read More » The post Pioneering initiative to Fast-Track Antimicrobials from R&D to commercialization appea ..read more

Agreement creates opportunity to offer end-to-end solutions for biopharma clients across Australia and New Zealand     Frankfurt, Germany – 12 April 2023: PharmaLex Group, the leading provider of specialized services for the pharma, biotech and medtech industries worldwide, has announced its intention to merge with Cpharm, the leading provider of pharmacovigilance and medical services in Australia and New Zealand.  The merger … PharmaLex expands Australia footprint through merger plan with pharmacovigilance leader Cpharm Read More » The post PharmaLex expands Australia foot ..read more

Acquisition advances role as a partner of choice for biopharmaceutical companies by enhancing global portfolio of specialty services CONSHOHOCKEN, PA, January 3, 2023 — AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of its acquisition of PharmaLex Holding GmbH. The acquisition of PharmaLex enhances AmerisourceBergen’s growth strategy by advancing its leadership in specialty services and global … AmerisourceBergen completes acquisition of PharmaLex Read More » The post AmerisourceBergen completes acquisition of PharmaLex appeared first on PharmaLex ..read more

Announcement of experienced PharmaLex leadership for BlueReg ensures strength and stability for the business amid ongoing integration   Frankfurt, Germany – 14 November 2022: PharmaLex Group, a leading provider of specialized services for the Pharma, Biotech and Medtech industries worldwide, has appointed experienced PharmaLex leader Sophie Guillaume as Managing Director of BlueReg, which recently merged with PharmaLex.   BlueReg was founded in … PharmaLex strengthens foothold in regulatory services after merger with strategic consultancy BlueReg Read More » The post Pharma ..read more

Agreement key to building pan-European market access practice while underscoring a think global, act local commitment     Frankfurt, Germany – 13th of October 2022: PharmaLex Group, the leading provider of specialised services for the pharma, biotech and MedTech industries worldwide, has announced a merger with UK pharmaceutical and healthcare services consultancy, NeoHealthHub Limited.    The agreement with NeoHealthHub (NHH), which was signed … PharmaLex strengthens its specialised services presence through merger with UK’s NeoHealthHub Read More » The post PharmaLex ..read more

Transaction further advances leadership in specialty, with key commercial enablement solutions to support biopharmaceutical partners CONSHOHOCKEN, PA, September 12, 2022 — AmerisourceBergen Corporation (NYSE: ABC) today announced that it has signed a definitive agreement to acquire PharmaLex Holding GmbH, a leading provider of specialized services for the life sciences industry, from AUCTUS Capital Partners AG … AmerisourceBergen to expand global biopharma services platform with acquisition of PharmaLex Read More » The post AmerisourceBergen to expand global biopharma services platform with ac ..read more

Opening of new office boosts PharmaLex’s APAC strategy and gives global clients access to regulatory expertise in key China market       Frankfurt, Germany – 1 September 2022: PharmaLex Group, a leading provider of specialized services for the pharma, biotech and medtech industries worldwide, has announced the opening of a new branch in Beijing, China, giving global clients access to a team … PharmaLex strengthens global reach and local support with offices in China Read More » The post PharmaLex strengthens global reach and local support with offices in China appeared ..read more

Alliance strengthens long-held collaboration and builds on overall regulatory, quality and market access services while advancing digital expertise     Frankfurt, Germany – 16 August 2022: PharmaLex Group, the leading provider of specialized services for the pharma, biotech and MedTech industries worldwide, has announced a merger with Finnish consulting company, DRA Consulting.  DRA Consulting will become part of the broader PharmaLex Nordic … PharmaLex expands Nordic footprint across key business units with DRA Consulting merger Read More » The post PharmaLex expands Nordic foo ..read more